Cancer With A High Tumor Mutational Burden
2 clinical trials · Condition
◉ Watch Cancer With A High Tumor Mutational Burden
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies (NCT05199272) | 23andMe, Inc. | 2021-12-29 |
| A Beta-only IL-2 ImmunoTherapY Study (NCT05086692) | Medicenna Therapeutics, Inc. | 2021-08-27 |
Track Cancer With A High Tumor Mutational Burden automatically
Every clearance here is in the API, with alerts when new ones post.